Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|October 9, 2020
Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association StudyThomas A Werfel, Donna J Hicks, Bushra Rahman, et al.
The Journal of Clinical Investigation|April 10, 2014
Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLCKatherine R Amato, Shan Wang, Andrew K Hastings, et al.
The Journal of Clinical Investigation|December 15, 2020
Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancerDeanna N Edwards, Verra M Ngwa, Ariel L Raybuck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cellsTodd W Miller, James T Forbes, Chirayu Shah, et al.
The Journal of Clinical Investigation|September 4, 2013
ErbB3 downregulation enhances luminal breast tumor response to antiestrogensMeghan M Morrison, Katherine Hutchinson, Michelle M Williams, et al.
Cancer Research Communications|February 28, 2025
Induction of Triple-Negative Breast Cancer Cell Death and Chemosensitivity Using mTORC2-Directed RNAi NanomedicineShrusti S Patel, Rebecca S Cook, Justin H Lo, et al.
Cancer Research|January 24, 2018
Selective mTORC2 Inhibitor Therapeutically Blocks Breast Cancer Cell Growth and SurvivalThomas A Werfel, Shan Wang, Meredith A Jackson, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Polymeric Micellar Nanoparticles Enable Image-guided Drug Delivery in Solid TumorsJashim Uddin, Justin Han-Je Lo, Mukesh K Gupta, et al.
Pageof 9